Severe early bilateral macular edema following fingolimod therapy

Multiple Sclerosis and Related Disorders

Volumn 2, Issue 3, 2013, Pages 256-258

  Coppes, Oscar Jim Michael ^a   Gutierrez, Ismael ^b   Reder, Anthony T ^c   Ksiazek, Susan ^c   Bernard, Jacqueline ^c  

^a UNIVERSITY OF CHICAGO   (United States)

^b ROSS UNIVERSITY SCHOOL OF MEDICINE   (Dominica)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Macular edema; Multiple sclerosis; Optic nerve; Optical coherence tomography; Retina; Vision loss

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; BETA INTERFERON; FINGOLIMOD; METFORMIN; METOPROLOL SUCCINATE; NATALIZUMAB; VERAPAMIL;

ADULT; AFRICAN AMERICAN; ARTICLE; BLURRED VISION; CASE REPORT; DISEASE SEVERITY; FEMALE; HIGH RISK PATIENT; HUMAN; MULTIPLE SCLEROSIS; OPHTHALMOLOGY; OPTICAL COHERENCE TOMOGRAPHY; RETINA FOVEA; RETINA MACULA EDEMA; RISK FACTOR; SCREENING TEST; VISUAL ACUITY;

EID: 84876412006     PISSN: 22110348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msard.2012.11.004     Document Type: Article

References (5)

1. FDA and CDER. Peripheral and central nervous system drugs advisory committee meeting: Fingolimod (NDA 22-527) background package; 2010.
2. V. Brinkmann, M.D. Davis, C.E. Heise, R. Albert, S. Cottens, and R. Hof The immune modulator FTY720 targets sphingosine 1-phosphate receptors Journal of Biological Chemistry 277 2002 21453 21457
3. N. Jain, and M.T. Bhatti Fingolimod-associated macular edema: incidence, detection, and management Neurology 78 9 2012 672 680
4. P.G. Tranos, S.S. Wickremaginghe, N.T. Stangos, F. Topouzis, I. Tsinopoulos, and C.E. Pavesio Macular edema Survey of Ophthalmology 49.5 2004 470 490
5. S.S. Zamvil, and L. Steinman Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis Neuron 2003 38685 38688